Advances in Managing NTRK Fusion-Positive CNS Cancers Managing Adverse Effects Associated With TRK Inhibitors

Advances in Managing NTRK Fusion-Positive CNS Cancers Managing Adverse Effects Associated With TRK Inhibitors is organized by Projects In Knowledge Inc. (PIK).

Release Date: Jun 01, 2023
Termination Date: May 31, 2024

Activity Goal:
The goal of this activity is to provide the most current clinical information and practical management strategies in treating CNS tumors, as seen in clinical practice, in a customized, interactive, and easily digestible on-demand educational program.

Learning Objective(s):
• Implement optimal strategies for identifying and managing adverse effects caused by tropomyosin receptor kinase inhibitors.

Additional details will be posted as soon as information is available.

0.5 MOC | 0.5 IPCE | 0.5 AMA PRA Category 1 Credit™ | 0.5 Contact Hours | 0.1 CEU